By Sarah Russo
The Society of Cannabis Clinicians (SCC), the first and oldest medical organization in the USA to advocate for the therapeutic use of cannabis, is pleased to announce the launch of a new Medical Cannabis Clinical Training Curriculum. This curriculum will enable clinicians to provide the best possible treatment to their patients while bridging the education gap between healthcare providers and the communities they serve. These courses provide the most comprehensive cannabinoid education for medical professionals to date.
Interest in cannabis is growing worldwide. A common denominator is a lack of clinical education and access to the latest reliable scientific data used to best guide patient care. Although the plant has been used medicinally for thousands of years, overriding political concerns of our current era have hindered research on its clinical benefits. A 2020 study found that only 18% of patients reported their provider was a good source of information on medical cannabis.
Education is Crucial
Without guidance, patients are left to figure out medical cannabis on their own. This may cause them to use products that are not well suited for their situation. They may try many options, some of which may be costly and unhelpful. In most cases, patients go to dispensary staff for guidance. The staff has neither the medical background nor know-how to navigate the patient’s health situation. While some states have pharmacists on staff, not all have been properly trained to adequately guide patients on cannabis.
Patients need professional insight to be able to manage safe medical cannabis use. Educated healthcare professionals can provide recommendations on timing and dosing, cannabinoid ratios, terpene profiles, and how to avoid polypharmacy issues or potential adverse reactions. Many patients use cannabis without clinician guidance to address situations and common medical challenges where they have found no relief.
SCC Clinical Training Curriculum
Knowledge is key to understanding how medical cannabis can help patients and minimize adverse effects. The SCC provides direct training for clinicians to stay up-to-date on key topics in medical cannabis to ensure best quality patient care. The SCC’s new Training Courses offer critical information missing from most health professional training schools and continuing clinical education programs.
SCC modules integrate the latest cannabis research and decades of combined clinical knowledge from 20 world-renowned experts and thought leaders in medical cannabis. The curriculum explores the underlying mechanisms of the endocannabinoid system, basics of laboratory analysis, and therapeutic implications for a wide range of conditions. Course authors share vital research and practice standards developed after treating thousands of patients.
There is a growing amount of information on cannabis available online, but it is often rife with misinformation. SCC courses explore scientifically supported evidence on the benefits and considerations of using medical cannabis. The intent is to empower medical graduates and healthcare professionals to discuss cannabis as a treatment option with patients. Courses are available for clinicians as well as pharmacists, midwives, nurses, dentists, podiatrists, therapists, acupuncturists, herbalists, nutritionists, health coaches and others.
Check out the course offerings here.
SCC courses can be taken home, at your own pace. Courses are available as individual modules or full course packages and include certificates of completion. The courses are optimized for desktop and mobile, and can be accessed from anywhere in the world. SCC members receive a discount on courses and as well as other perks of being part of the organization.
More about the Society of Cannabis Clinicians
The Society of Cannabis Clinicians is a nonprofit educational and scientific society of healthcare professionals and allies dedicated to advancing research and disseminating knowledge about medical cannabis. Through expanding educational advocacy, the SCC now has members in 23 countries and growing. The organization has chapters in Latin America, Australia, and the United Kingdom.
The SCC was founded in 1999 by Tod Mikuriya, MD. Dr. Mikuriya started the organization with several other physicians to discuss their respective medical cases and to observe patients using cannabis treatment. Regarded by some as the Grandfather of the Medical Cannabis Movement, Dr. Mikuriya introduced and approved the plant for over nine thousand patients.
Fred Gardner, journalist and former Scientific American editor, wanted to document Tod’s clinical cases. They started O’Shaughnessy’s: the Journal of Cannabis in Clinical Practice which continues to this day. The SCC was formed to highlight the mass accumulation of clinical evidence that can serve as the basis for clinical trials. The organization continually advocates for the education of healthcare professionals and the patients that they serve.
Learn more about the SCC by visiting their website and exploring their courses. Check out the promo video to learn more about the SCC courses.
The post New Medical Cannabis Clinical Training Curriculum from the Society of Cannabis Clinicians appeared first on CANORML.
“New Mexico joins an ever-growing list of states that have realized the failures of marijuana prohibition and the harms it brings to their communities and citizens.”
The post New Mexico: Governor Signs Marijuana Legalization, Automatic Expungement Measures into Law appeared first on NORML.
Welcome to the latest edition of NORML’s Weekly Legislative Rooundup, on the blog every Friday!
The post Weekly Legislative Roundup 4/9/21 appeared first on NORML.
Locals in Delaware are tangling with corporate, multi-state medical marijuana permit holders to pass a bill for full legalization.
The post Delaware: Cannabis Activists Take on Corporate Marijuana, Patients Stage Boycott appeared first on NORML.
Virginia becomes the first southern state to legalize the possession and use of marijuana by adults.
The post Virginia: Legalization of Adult-use Marijuana Takes Effect July 1, 2021 appeared first on NORML.
“At 100 percent of the recreational marijuana outlets visited, the pseudo-underage patrons were required to show age identification to enter.”
The post California: Study Finds 100% of Marijuana Retailers Compliant with State’s Minimum Age Laws appeared first on NORML.
It’s April and that means 4/20 is upon us! To celebrate, Cal NORML is offering $420 yearly business memberships (regularly priced at $500) through April 30. Memberships can also be purchased for $42/month.
As a California NORML business member you’ll be listed in one of the Cannabis Marketplace Directories on CaNORML.org, our longstanding website with 1.63 million yearly page views. Directory categories include Dispensaries & Delivery, Legal Services, Cannabis Products, Cannabis Business Services, and Vaporizer Resources.
Additional benefits of business membership include the ability to sponsor our weekly eNewsletter or publish a guest blog post, and discounts on NCIA memberships. Become a Cal NORML Business Member or learn more.
Also this month, 420 club members who purchase a personal yearly Cal NORML membership of $42 or more, will be sent a groovy Vintage Cal NORML lapel magnet. Join the 420 Club!
In addition, to celebrate the 25th anniversary of Prop. 215 (which legalized medical marijuana in California in 1996), we are offering a special EarlyBird price on our upcoming Legal Seminar. For $215 you can attend both days of the Zoom event (June 1 & 2). Attorneys can earn up to 8.5 hours of CLE credit (pending) for attending. Learn the latest on civil and criminal law in California from top attorneys in the field. Sign up for our Legal Seminar.
Support Cal NORML this April and save!
Founded in 1972, Cal NORML advocates for the rights of cannabis consumers in California. Read more about Cal NORML and our 2020 Accomplishments and Plans for 2021.
The post April Specials on Cal NORML Memberships and Events appeared first on CANORML.
March 31, 2021 – Consumers wishing to buy products to vape cannabis oils may want to make their purchases ASAP before vape companies and shippers move to comply with a new US law banning shipment of certain vaporizer products. We have heard from one company that will cease shipping to certain CA zip codes as of noon tomorrow (April 1 – no fooling).
The law should not affect devices used to vape dry herb or waxes, only oils.
According to a recent article in MJ Biz Daily:
The legislation takes effect in late March, after which the USPS has 120 days to create rules to implement the law.
FedEx and UPS already have said they will follow the U.S. Postal Service’s directive and won’t ship vaping products.
“Effective April 5, 2021, UPS will not transport vaping products to, from or within the United States due to the increased complexity to ship those products,” Matthew O’Connor, a UPS spokesman, said in a statement.
While the law is directed at nicotine products, it arguably includes cannabis oil products by banning shipment of:
“any electronic device that, through an aerosolized solution, delivers nicotine, flavor, or any other substance to the user inhaling from the device,” including “an e-cigarette; an e-hookah; an e-cigar; a vape pen; an advanced refillable personal vaporizer; an electronic pipe; and any component, liquid, part, or accessory of a device described [above], without regard to whether the component, liquid, part, or accessory is sold separately from the device.”
Cal NORML has promoted vaporization as a valuable harm reduction tool for reducing exposure to harmful smoke toxins since sponsoring the first scientific studies on vaping in 1996 and 2001. We objected to USPS’s new rule and NORML put out an action alert on it.
The post ALERT: USPS, Other Shippers to Cease Sending Cannabis Oil Vape Products appeared first on CANORML.